Muscle or joint pain is one of the most common symptoms during menopausal transition. As this could be severe enough to affect social and daily life and to reduce quality of life, attentions should be paid about this. Although understanding of muscle or joint pain related to menopause is still insufficient, estrogen can play an important role. Previous studies have shown that estrogen protects cartilage in both animals and humans. However, perimenopause is different from postmenopause, in the point that estrogen is still secreted with a great fluctuation. Until now, no study has been performed to evaluate the effects of oral contraceptive on muscle or joint pain in women during menopausal transition. Moreover, since menopausal symptoms vary according to ethnicity and culture, a study in Korean population is necessary. Therefore, this randomized controlled trial was designed to evaluate the effects of oral contraceptive on muscle or joint pain in women during menopausal transition, compared to NSAID (non-steroidal anti-inflammatory drug).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
52
ethinyl estradiol 0.03mg/levonorgestrel 0.15mg daily for 8 weeks
ibuprofen 200mg/arginine 185mg twice per day for 8 weeks
Samsung Medical Center
Seoul, Gangnam-gu, South Korea
RECRUITINGimprovement in symptoms
evaluated by fibromyalgia impact questionnaire and visual analogue scale
Time frame: Eight weeks
quality of life
evaluated by SF-12
Time frame: Eight weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.